An article published today by Bloomberg News sheds a harsh light on the problems inherent in the for-profit hospice industry. The article cites interviews with industry professionals and grizzly anecdotes from numerous lawsuits to confirm the obvious: that the goal of for-profits – making money – is in inescapable conflict with the proper goal of hospice care – providing comfort and palliation for terminally ill patients. The article specifically identifies giants Vitas and Odessey/Gentiva as companies coming under increasing scrutiny.
To report hospice fraud contact Frohsin & Barger.
[…] hospice benefit has come under greater scrutiny with recent reports in the New York Times, NPR, and Bloomberg News all indicating that for-profit hospice providers may be manipulating the benefit to post huge […]